Martha Brown, M.D., Assistant Director at PRN, provided a presentation on disruptive physicians to the Board at their meeting held August 7, 2015 in Tampa, Florida. Dr. Brown discussed how disruptive behavior leads to miscommunication and potentially patient harm. To read the presentation click here.
More Latest News
February 12, 2019
The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa. Continue reading